Search Results 1311-1320 of 17033 for monoclonal antibody
Patients with known Positive Hepatitis B Surface Antigen (HepBsAg) (indicative of chronic Hepatitis B), positive Hepatitis total core antibody with negative ...
... antibody in combination with cytotoxic, platinum-based chemotherapy OR who have experienced disease progression following treatment an anti-PD-(L)1 antibody ...
Monoclonal gammopathy. Nelson Leung, M.D., studies kidney diseases caused by monoclonal ... Schinstock studies therapy for chronic antibody-mediated rejection ...
Prior anti-VEGF targeted monoclonal antibody therapies (e.g., bevacizumab and ramucirumab) are permitted. Treatment with any previous drug therapy within 2 ...
UP-NEXT is a double-blind, randomized, placebo controlled study of the antibody-drug conjugate (ADC) XMT-1536 (upifitamab rilsodotin) administered as an ...
Transplant Immunology Program. Sections. Overview · Faculty and staff; Research Research. Antibody Barriers Project ... alloantibody testing. Biobanking of ...
... antibodies and the factors that may determine disease progression and treatment response. A Study to Evaluate the Role of Gut Microbiome in Cancer Therapy.
Serum monoclonal protein ≥ 1.0 g/dL; ≥ 200 mg of monoclonal protein in the ... Monoclonal bone marrow plasmacytosis ≥ 30% (evaluable disease) at time of ...
Has a known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies). Has active autoimmune disease that has required systemic treatment in the ...
... antibodies to protect against others. Significant advances in technology — paired with understanding the complexities of the immune system and its role in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.